{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:24:54Z","timestamp":1793345094613,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.2119\/molmed.2014.00185","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T17:36:49Z","timestamp":1554485809000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["C1q-Mediated Repression of Human Monocytes Is Regulated by Leukocyte-Associated Ig-Like Receptor 1 (LAIR-1)"],"prefix":"10.1186","volume":"20","author":[{"given":"Myoungsun","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"key":"2001559_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.semarthrit.2008.11.002","volume":"39","author":"CG Katsiari","year":"2010","unstructured":"Katsiari CG, Liossis SN, Sfikakis PP. (2010) The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin. Arthritis Rheum. 39:491\u2013503.","journal-title":"Semin. Arthritis Rheum."},{"key":"2001559_CR2","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","volume":"180","author":"PY Lee","year":"2008","unstructured":"Lee PY, et al. (2008) A novel type I IFN-producing cell subset in murine lupus. J. Immunol. 180:5101\u20138.","journal-title":"J. Immunol."},{"key":"2001559_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00005-010-0093-y","volume":"58","author":"Y Li","year":"2010","unstructured":"Li Y, Lee PY, Reeves WH. (2010) Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch. Immunol. Ther. Exp. (Warsz). 58:355\u201364.","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"2001559_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/art.33395","volume":"64","author":"RC Stone","year":"2012","unstructured":"Stone RC, et al. (2012) Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum. 64:788\u201398.","journal-title":"Arthritis Rheum."},{"key":"2001559_CR5","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.4049\/jimmunol.1201162","volume":"189","author":"L Yang","year":"2012","unstructured":"Yang L, Feng D, Bi X, Stone RC, Barnes BJ. (2012) Monocytes from Irf5\u2212\/\u2212 mice have an intrinsic defect in their response to pristane-induced lupus. J. Immunol. 189:3741\u201350.","journal-title":"J. Immunol."},{"key":"2001559_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.clim.2008.01.014","volume":"127","author":"L Hansmann","year":"2008","unstructured":"Hansmann L, Groeger S, von Wulffen W, Bein G, Hackstein H. (2008) Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin. Immunol. 127:252\u201364.","journal-title":"Clin. Immunol."},{"key":"2001559_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/0961203313519157","volume":"23","author":"F Kanakoudi-Tsakalidou","year":"2014","unstructured":"Kanakoudi-Tsakalidou F, et al. (2014) Simultaneous changes in serum HMGB1 and IFN-alpha levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE: new therapeutic options? Lupus. 23:305\u201312.","journal-title":"Lupus"},{"key":"2001559_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/sj.gene.6364408","volume":"8","author":"TB Niewold","year":"2007","unstructured":"Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. (2007) High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 8:492\u2013502.","journal-title":"Genes Immun."},{"key":"2001559_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U","volume":"32","author":"P Ahmad-Nejad","year":"2002","unstructured":"Ahmad-Nejad P, et al. (2002) Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958\u201368.","journal-title":"Eur. J. Immunol."},{"key":"2001559_CR10","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1073\/pnas.161293498","volume":"98","author":"S Bauer","year":"2001","unstructured":"Bauer S, et al. (2001) Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 98:9237\u201342.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2001559_CR11","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi H, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature. 408:740\u20135.","journal-title":"Nature"},{"key":"2001559_CR12","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1083\/jcb.200508058","volume":"172","author":"MA Sanjuan","year":"2006","unstructured":"Sanjuan MA, et al. (2006) CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J. Cell Biol. 172:1057\u201368.","journal-title":"J. Cell Biol."},{"key":"2001559_CR13","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.4049\/jimmunol.1100115","volume":"187","author":"M Saxena","year":"2011","unstructured":"Saxena M, Busca A, Pandey S, Kryworuchko M, Kumar A. (2011) CpG protects human monocytic cells against HIV-Vpr-induced apoptosis by cellular inhibitor of apoptosis-2 through the calcium-activated JNK pathway in a TLR9-independent manner. J. Immunol. 187:5865\u201378.","journal-title":"J. Immunol."},{"key":"2001559_CR14","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","volume":"170","author":"M Kerkmann","year":"2003","unstructured":"Kerkmann M, et al. (2003) Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170:4465\u201374.","journal-title":"J. Immunol."},{"key":"2001559_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.4161\/onci.19731","volume":"1","author":"H Shirota","year":"2012","unstructured":"Shirota H, Klinman DM. (2012) Effect of CpG ODN on monocytic myeloid derived suppressor cells. Oncoimmunology. 1:780\u20132.","journal-title":"Oncoimmunology"},{"key":"2001559_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","volume":"8","author":"M Gilliet","year":"2008","unstructured":"Gilliet M, Cao W, Liu YJ. (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8:594\u2013606.","journal-title":"Nat. Rev. Immunol."},{"key":"2001559_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.trsl.2011.01.006","volume":"157","author":"R Salloum","year":"2011","unstructured":"Salloum R, Niewold TB. (2011) Interferon regulatory factors in human lupus pathogenesis. Transl. Res. 157:326\u201331.","journal-title":"Transl. Res."},{"key":"2001559_CR18","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1182\/blood-2010-07-294272","volume":"117","author":"P Li","year":"2011","unstructured":"Li P, et al. (2011) IRF8 and IRF3 cooperatively regulate rapid interferon-beta induction in human blood monocytes. Blood. 117:2847\u201354.","journal-title":"Blood"},{"key":"2001559_CR19","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1111\/j.1432-1033.2004.04310.x","volume":"271","author":"H Yang","year":"2004","unstructured":"Yang H, Ma G, Lin CH, Orr M, Wathelet MG. (2004) Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. Eur. J. Biochem. 271:3693\u2013703.","journal-title":"Eur. J. Biochem."},{"issue":"Suppl1","key":"2001559_CR20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar2883","volume":"12","author":"AM Delgado-Vega","year":"2010","unstructured":"Delgado-Vega AM, Alarcon-Riquelme ME, Kozyrev SV. (2010) Genetic associations in type I interferon related pathways with autoimmunity. Arthritis Res. Ther. 12 Suppl 1:S2.","journal-title":"Arthritis Res. Ther."},{"key":"2001559_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T. (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644\u201358.","journal-title":"Nat. Rev. Immunol."},{"key":"2001559_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka A, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Tolllike receptors. Nature. 434:243\u20139.","journal-title":"Nature"},{"key":"2001559_CR23","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/eji.201242792","volume":"43","author":"F Steinhagen","year":"2013","unstructured":"Steinhagen F, et al. (2013) IRF-5 and NF-kappaB p50 co-regulate IFN-beta and IL-6 expression in TLR9-stimulated human plasmacytoid dendritic cells. Eur. J. Immunol. 43:1896\u2013906.","journal-title":"Eur. J. Immunol."},{"key":"2001559_CR24","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1177\/0961203308089340","volume":"17","author":"M Akahoshi","year":"2008","unstructured":"Akahoshi M, et al. (2008) Promoter polymorphisms in the IRF3 gene confer protection against systemic lupus erythematosus. Lupus 17:568\u201374.","journal-title":"Lupus"},{"key":"2001559_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/sj.onc.1202176","volume":"17","author":"PL Schwartzberg","year":"1998","unstructured":"Schwartzberg PL. (1998) The many faces of Src: multiple functions of a prototypical tyrosine kinase. Oncogene. 17:1463\u20138.","journal-title":"Oncogene"},{"key":"2001559_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ni.2246","volume":"13","author":"I Rhee","year":"2012","unstructured":"Rhee I, Veillette A. (2012) Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat. Immunol. 13:439\u201347.","journal-title":"Nat. Immunol."},{"key":"2001559_CR27","doi-asserted-by":"crossref","first-page":"24249","DOI":"10.1016\/S0021-9258(18)54220-4","volume":"266","author":"M Okada","year":"1991","unstructured":"Okada M, Nada S, Yamanashi Y, Yamamoto T, Nakagawa H. (1991) CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J. Biol. Chem. 266:24249\u201352.","journal-title":"J. Biol. Chem."},{"key":"2001559_CR28","doi-asserted-by":"publisher","first-page":"e15080","DOI":"10.1371\/journal.pone.0015080","volume":"5","author":"I Bonaccorsi","year":"2010","unstructured":"Bonaccorsi I, et al. (2010) The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNalpha production. PLoS One. 5:e15080.","journal-title":"PLoS One"},{"key":"2001559_CR29","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3160::AID-IMMU3160>3.0.CO;2-S","volume":"29","author":"AR Vuurst de Vries van der","year":"1999","unstructured":"van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L. (1999) Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling. Eur. J. Immunol. 29:3160\u20137.","journal-title":"Eur. J. Immunol."},{"key":"2001559_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1189\/jlb.0907609","volume":"83","author":"L Meyaard","year":"2008","unstructured":"Meyaard L. (2008) The inhibitory collagen receptor LAIR-1 (CD305). J. Leukoc. Biol. 83:799\u2013803.","journal-title":"J. Leukoc. Biol."},{"key":"2001559_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1074-7613(00)80530-0","volume":"7","author":"L Meyaard","year":"1997","unstructured":"Meyaard L, et al. (1997) LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 7:283\u201390.","journal-title":"Immunity"},{"key":"2001559_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4049\/jimmunol.1102044","volume":"188","author":"X Tang","year":"2012","unstructured":"Tang X, et al. (2012) Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype. J. Immunol. 188:548\u201358.","journal-title":"J. Immunol."},{"key":"2001559_CR33","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1002\/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T","volume":"28","author":"A Poggi","year":"1998","unstructured":"Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L. (1998) p40\/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur. J. Immunol. 28:2086\u201391.","journal-title":"Eur. J. Immunol."},{"key":"2001559_CR34","doi-asserted-by":"publisher","first-page":"E3160","DOI":"10.1073\/pnas.1212753109","volume":"109","author":"M Son","year":"2012","unstructured":"Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. (2012) C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc. Natl. Acad. Sci. U. S. A. 109:E3160\u20137.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2001559_CR35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/intimm\/dxg134","volume":"15","author":"A Verbrugge","year":"2003","unstructured":"Verbrugge A, Ruiter Td T, Clevers H, Meyaard L. (2003) Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment. Int. Immunol. 15:1349\u201358.","journal-title":"Int. Immunol."},{"key":"2001559_CR36","doi-asserted-by":"publisher","first-page":"17440","DOI":"10.1074\/jbc.M001313200","volume":"275","author":"M Xu","year":"2000","unstructured":"Xu M, Zhao R, Zhao ZJ. (2000) Identification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cells. J. Biol. Chem. 275:17440\u20136.","journal-title":"J. Biol. Chem."},{"key":"2001559_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/cimm.1998.1272","volume":"185","author":"AR Khaled","year":"1998","unstructured":"Khaled AR, Butfiloski EJ, Sobel ES, Schiffenbauer J. (1998) Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B. Cell. Immunol. 185:49\u201358.","journal-title":"Cell. Immunol."},{"key":"2001559_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.coi.2012.08.004","volume":"24","author":"KB Elkon","year":"2012","unstructured":"Elkon KB, Santer DM. (2012) Complement, interferon and lupus. Curr. Opin. Immunol. 24:665\u201370.","journal-title":"Curr. Opin. Immunol."},{"key":"2001559_CR39","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1002\/art.24852","volume":"60","author":"C Lood","year":"2009","unstructured":"Lood C, et al. (2009) C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 60:3081\u201390.","journal-title":"Arthritis Rheum."},{"key":"2001559_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/eji.200324026","volume":"34","author":"M Yamada","year":"2004","unstructured":"Yamada M, et al. (2004) Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur. J. Immunol. 34:221\u201330.","journal-title":"Eur. J. Immunol."},{"key":"2001559_CR41","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.4049\/jimmunol.1001731","volume":"185","author":"DM Santer","year":"2010","unstructured":"Santer DM, et al. (2010) C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. J. Immunol. 185:4738\u201349.","journal-title":"J. Immunol."},{"key":"2001559_CR42","doi-asserted-by":"crossref","unstructured":"Byrne JC, et al. (2012) Genetics of SLE: functional relevance for monocytes\/macrophages in disease. Clin. Dev. Immunol. 2012:582352.","DOI":"10.1155\/2012\/582352"},{"key":"2001559_CR43","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1189\/jlb.0603255","volume":"74","author":"A Izaguirre","year":"2003","unstructured":"Izaguirre A, et al. (2003) Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74:1125\u201338.","journal-title":"J. Leukoc. Biol."},{"key":"2001559_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM197907053010102","volume":"301","author":"JJ Hooks","year":"1979","unstructured":"Hooks JJ, et al. (1979) Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:5\u20138.","journal-title":"N. Engl. J. Med."},{"key":"2001559_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","volume":"25","author":"J Banchereau","year":"2006","unstructured":"Banchereau J, Pascual V. (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 25:383\u201392.","journal-title":"Immunity"},{"key":"2001559_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/0891693031000152660","volume":"36","author":"K Omagari","year":"2003","unstructured":"Omagari K, et al. (2003) Anti-extractable nuclear antigens (ENA) antibodies in patients with chronic hepatitis C before and after treatment with interferon. Autoimmunity. 36:269\u201373.","journal-title":"Autoimmunity"},{"key":"2001559_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00296-010-1636-6","volume":"32","author":"CY Ma","year":"2012","unstructured":"Ma CY, et al. (2012) Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol. Int. 32:395\u2013402.","journal-title":"Rheumatol. Int."},{"key":"2001559_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1189\/jlb.3AB0213-092RR","volume":"96","author":"MJ Olde Nordkamp","year":"2014","unstructured":"Olde Nordkamp MJ, et al. (2014) Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D. J. Leukoc. Biol. 96:105\u201311.","journal-title":"J. Leukoc. Biol."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2014.00185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2014.00185\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2014.00185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:38:28Z","timestamp":1663238308000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2014.00185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2001559"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2014.00185","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"15 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}